Nemours Children's Clinic

The Nemours Children's Clinic, operating under The Nemours Foundation, is a non-profit pediatric health system dedicated to improving children's health through clinical care, research, and education. As a renowned pediatric healthcare organization, Nemours provides specialized medical services, conducts biomedical research, and implements preventative health programs targeting childhood diseases and disorders. Through federal grant awards, Nemours offers a wide range of pediatric specialty healthcare services, cutting-edge medical research initiatives, and comprehensive care coordination programs. The organization leverages its expertise in pediatric medicine to secure grants from various federal agencies, enabling it to advance its mission of enhancing children's health outcomes.

Nemours has received numerous federal grant awards to support diverse pediatric research and clinical initiatives. Major areas of focus include studies on rare genetic disorders such as tuberous sclerosis complex, Morquio A disease, and sex chromosome trisomies. The organization has conducted clinical trials for novel treatments in pediatric cancer, particularly acute myeloid leukemia, and investigated childhood obesity, hypertension, and cardiovascular health. Nemours has also led research on neonatal and infant health issues, including respiratory distress syndrome. Federal funding has supported the construction of specialized clinical facilities for treating pediatric cancer, blood disorders, and vascular malformations. Additionally, grants have funded research on healthy adaptation and resilience to chronic pain in adolescents and young adults, improving self-management and glycemic control in youth with type 1 diabetes, and reducing hypoglycemic fear in parents of young children with diabetes. Key funding sources include various National Institutes of Health institutes, the Substance Abuse and Mental Health Services Administration, and the Department of Defense Medical Command. Nemours frequently collaborates with academic institutions and hospitals as both a prime recipient and sub-awardee on multi-site studies, supporting clinical trials led by children's hospitals and research institutes investigating personalized medicine approaches and inflammatory bowel disease treatments.